The Drug Information Association (DIA), in cooperation with PhRMA, will host a workshop on Dried Blood Spot Sampling in the Pharmaceutical Industry: Methodology, Implementation and Best Practices on December 8, 2009 in Washington, DC.
Horsham, PA, USA (Vocus) November 13, 2009 -- The Drug Information Association (DIA), in cooperation with PhRMA, will host a workshop on Dried Blood Spot Sampling in the Pharmaceutical Industry: Methodology, Implementation and Best Practices on December 8, 2009 in Washington, DC.
Dried blood spot (DBS) sampling on specialty papers is a novel methodology in the area of pharmacokinetics and toxicokinetics that serves to replace conventional plasma analysis for pharmaceutical development. The most notable advantage of this technique is the reduced blood collection volume requirements and ease of sample manipulation.
This one-day workshop will feature three cross-functional parallel tracks in toxicology/safety assessment (and in vivo considerations), bioanalytical, and pharmacokinetics/clinical that will:
About the Drug Information Association (DIA)
A non-profit, neutral, multidisciplinary, global, member-driven association, DIA serves more than 30,000 professionals involved in the biopharmaceutical industry, academia, research organizations and governmental bodies worldwide. Through its domestic and international meetings, training courses, workshops and webinars, DIA provides a neutral global forum for the exchange of information critical to the advancement of drug development and medical product lifecycle management. DIA is led by its volunteer Board of Directors and executive management team, has headquarters in Horsham, PA, USA, and offices in Basel, Switzerland, Tokyo, Japan, Mumbai, India, and Beijing, China. For more information, visit www.diahome.org or call 215-442-6100.
Joe.Krasowski (at) diahome (dot) org
Read the full story at http://www.prweb.com/releases/dia_phrma/dried-blood-sampling/prweb3200984.htm.
Copyright©2009 Vocus, Inc.
All rights reserved